Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | SAVA |
---|---|---|
09:32 ET | 26891 | 31.3201 |
09:34 ET | 9705 | 31.9 |
09:36 ET | 26652 | 31.75 |
09:38 ET | 16732 | 31.8199 |
09:39 ET | 23299 | 31.6567 |
09:41 ET | 39934 | 31.115 |
09:43 ET | 10884 | 31.265 |
09:45 ET | 5000 | 31.19 |
09:48 ET | 41497 | 30.94 |
09:50 ET | 10460 | 31.015 |
09:52 ET | 5822 | 31.065 |
09:54 ET | 5750 | 31.16 |
09:56 ET | 5775 | 31.36 |
09:57 ET | 15862 | 30.7617 |
09:59 ET | 18424 | 30.58 |
10:01 ET | 39642 | 30.35 |
10:03 ET | 8899 | 30.48 |
10:06 ET | 7878 | 30.431 |
10:08 ET | 6473 | 30.4 |
10:10 ET | 19877 | 30.6804 |
10:12 ET | 23322 | 30.9399 |
10:14 ET | 40413 | 31.36 |
10:15 ET | 10495 | 31.18 |
10:17 ET | 13667 | 31.58 |
10:19 ET | 20099 | 31.57 |
10:21 ET | 7014 | 31.37 |
10:24 ET | 3794 | 31.3 |
10:26 ET | 1450 | 31.425 |
10:28 ET | 4864 | 31.63 |
10:30 ET | 3760 | 31.741 |
10:32 ET | 11119 | 31.25 |
10:33 ET | 6153 | 31.31 |
10:35 ET | 7490 | 31.305 |
10:37 ET | 1201 | 31.41 |
10:39 ET | 7432 | 31.39 |
10:42 ET | 1185 | 31.435 |
10:44 ET | 9859 | 31.05 |
10:46 ET | 1225 | 31.3 |
10:48 ET | 35836 | 30.85 |
10:50 ET | 16936 | 30.57 |
10:51 ET | 9942 | 30.4 |
10:53 ET | 9116 | 30.4 |
10:55 ET | 17964 | 30.16 |
10:57 ET | 37218 | 29.92 |
11:00 ET | 14131 | 30.27 |
11:02 ET | 3042 | 30.3181 |
11:04 ET | 3926 | 30.31 |
11:06 ET | 1579 | 30.341 |
11:08 ET | 6637 | 30.43 |
11:09 ET | 1890 | 30.33 |
11:11 ET | 500 | 30.525 |
11:13 ET | 3387 | 30.61 |
11:15 ET | 3583 | 30.5 |
11:18 ET | 969 | 30.5 |
11:20 ET | 859 | 30.35 |
11:22 ET | 545 | 30.39 |
11:24 ET | 500 | 30.31 |
11:26 ET | 1000 | 30.335 |
11:27 ET | 2326 | 30.33 |
11:29 ET | 9100 | 30.2898 |
11:31 ET | 4952 | 30.4137 |
11:33 ET | 875 | 30.45 |
11:36 ET | 11850 | 30.37 |
11:38 ET | 678 | 30.425 |
11:40 ET | 2819 | 30.455 |
11:42 ET | 2850 | 30.28 |
11:44 ET | 9378 | 30.23 |
11:45 ET | 1239 | 30.12 |
11:47 ET | 1050 | 30.095 |
11:49 ET | 5001 | 30.12 |
11:51 ET | 100 | 30.12 |
11:54 ET | 1130 | 30.13 |
11:56 ET | 1708 | 30.25 |
11:58 ET | 442 | 30.1883 |
12:00 ET | 2850 | 30.0891 |
12:02 ET | 11920 | 29.9039 |
12:03 ET | 5300 | 30.0543 |
12:05 ET | 1711 | 30.04 |
12:07 ET | 936 | 30.21 |
12:09 ET | 300 | 30.2496 |
12:12 ET | 4047 | 30.17 |
12:14 ET | 7895 | 30.2 |
12:16 ET | 8861 | 30.03 |
12:18 ET | 4393 | 29.9207 |
12:20 ET | 18958 | 29.9299 |
12:21 ET | 1500 | 30 |
12:23 ET | 11211 | 30.16 |
12:25 ET | 14800 | 30.185 |
12:27 ET | 4672 | 30.35 |
12:30 ET | 2034 | 30.22 |
12:32 ET | 100 | 30.116 |
12:34 ET | 3217 | 30.3 |
12:36 ET | 3191 | 30.39 |
12:38 ET | 3456 | 30.37 |
12:39 ET | 962 | 30.395 |
12:41 ET | 1102 | 30.345 |
12:43 ET | 1204 | 30.37 |
12:45 ET | 1480 | 30.35 |
12:48 ET | 2003 | 30.46 |
12:50 ET | 1774 | 30.406 |
12:52 ET | 2411 | 30.41 |
12:54 ET | 100 | 30.39 |
12:56 ET | 593 | 30.4525 |
12:57 ET | 600 | 30.55 |
12:59 ET | 1772 | 30.53 |
01:01 ET | 500 | 30.5172 |
01:03 ET | 1124 | 30.5338 |
01:06 ET | 718 | 30.44 |
01:08 ET | 900 | 30.51 |
01:12 ET | 1100 | 30.46 |
01:14 ET | 2548 | 30.5 |
01:15 ET | 3072 | 30.54 |
01:17 ET | 1851 | 30.4418 |
01:21 ET | 762 | 30.2979 |
01:24 ET | 2634 | 30.1999 |
01:26 ET | 3008 | 30.0675 |
01:30 ET | 2672 | 30.3 |
01:32 ET | 170 | 30.26 |
01:33 ET | 1321 | 30.383 |
01:37 ET | 3508 | 30.39 |
01:39 ET | 200 | 30.4101 |
01:42 ET | 305 | 30.3849 |
01:44 ET | 1422 | 30.34 |
01:48 ET | 800 | 30.42 |
01:50 ET | 457 | 30.395 |
01:51 ET | 900 | 30.405 |
01:53 ET | 3000 | 30.55 |
01:55 ET | 6304 | 30.51 |
01:57 ET | 2600 | 30.68 |
02:00 ET | 5985 | 30.795 |
02:02 ET | 10618 | 31.21 |
02:04 ET | 30472 | 31.49 |
02:06 ET | 21177 | 31.1 |
02:08 ET | 13553 | 30.9723 |
02:09 ET | 14903 | 30.765 |
02:11 ET | 7669 | 30.715 |
02:13 ET | 14286 | 30.56 |
02:15 ET | 3050 | 30.51 |
02:18 ET | 23121 | 30.69 |
02:20 ET | 5200 | 30.8 |
02:22 ET | 9300 | 31.0695 |
02:24 ET | 3902 | 30.985 |
02:26 ET | 7346 | 31.1304 |
02:27 ET | 850 | 31.27 |
02:29 ET | 2870 | 31.3271 |
02:31 ET | 5339 | 31.5486 |
02:33 ET | 9321 | 31.5 |
02:36 ET | 7418 | 31.68 |
02:38 ET | 9259 | 31.58 |
02:40 ET | 5940 | 31.85 |
02:42 ET | 26879 | 32.1 |
02:44 ET | 21924 | 31.8098 |
02:45 ET | 6106 | 31.49 |
02:47 ET | 15473 | 31.74 |
02:49 ET | 4247 | 31.37 |
02:51 ET | 2547 | 31.465 |
02:54 ET | 4253 | 31.54 |
02:56 ET | 1722 | 31.595 |
02:58 ET | 1840 | 31.59 |
03:00 ET | 7232 | 31.33 |
03:02 ET | 13177 | 31.26 |
03:03 ET | 33771 | 30.62 |
03:05 ET | 8473 | 30.6504 |
03:07 ET | 9868 | 30.43 |
03:09 ET | 2200 | 30.67 |
03:12 ET | 900 | 30.674 |
03:14 ET | 6786 | 30.89 |
03:16 ET | 10874 | 30.88 |
03:18 ET | 3415 | 30.73 |
03:20 ET | 2163 | 30.68 |
03:21 ET | 7489 | 30.52 |
03:23 ET | 6041 | 30.58 |
03:25 ET | 1204 | 30.72 |
03:27 ET | 1666 | 30.85 |
03:30 ET | 2500 | 31.025 |
03:32 ET | 1214 | 30.76 |
03:34 ET | 2387 | 30.8119 |
03:36 ET | 5673 | 30.68 |
03:38 ET | 2206 | 30.525 |
03:39 ET | 1649 | 30.645 |
03:41 ET | 4492 | 30.51 |
03:43 ET | 1938 | 30.495 |
03:45 ET | 13943 | 30.43 |
03:48 ET | 5279 | 30.45 |
03:50 ET | 3925 | 30.45 |
03:52 ET | 4904 | 30.42 |
03:54 ET | 5526 | 30.415 |
03:56 ET | 8699 | 30.4995 |
03:57 ET | 32573 | 30.32 |
03:59 ET | 81395 | 30.32 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Cassava Sciences Inc | 1.5B | -74.8x | --- |
Belite Bio Inc | 1.5B | -39.4x | --- |
Syndax Pharmaceuticals Inc | 1.5B | -5.3x | --- |
Kura Oncology Inc | 1.5B | -9.1x | --- |
Spyre Therapeutics Inc | 1.4B | -1.9x | --- |
Disc Medicine Inc | 1.4B | -13.0x | --- |
Cassava Sciences, Inc. is a clinical-stage biopharmaceutical company focused on neuroscience. The Company's science is based on stabilizing, but not removing, a critical protein in the Alzheimer’s brain. Its scientific approach for the treatment of Alzheimer's disease seeks to simultaneously suppress both neurodegeneration and neuroinflammation. It has two biopharmaceutical assets under development: Simufilam and SavaDx. Simufilam, its lead therapeutic product candidate, is an oral treatment for Alzheimer’s disease dementia. Simufilam targets an altered form of a protein called filamin A (FLNA) in the Alzheimer’s brain. It is conducting two randomized placebo-controlled Phase III clinical trials of oral simufilam in patients with Alzheimer’s disease dementia. SavaDx, its lead investigational diagnostic product candidate, is a way to detect the presence of Alzheimer’s disease from a small sample of blood. SavaDx is a research-use only, non-safety related exploratory biomarker.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.5B |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 48.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.61 |
EPS | $-0.41 |
Book Value | $3.25 |
P/E Ratio | -74.8x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.